While future studies (e.g., SREBP1/PLIN2 silencing) are needed to confirm a direct causal link between LD regulation and hUC‐MSC function, our findings highlight the therapeutic potential of hUC‐MSCs in age‐related neurodegenerative disorders. Here, PLIN2 is linked to age.